Navigation Links
Upsher-Smith Introduces New Formulation of PreNexa® Prenatal Vitamins
Date:6/1/2010

MAPLE GROVE, Minn., June 1 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. announces the availability of a new formulation of PreNexa® Rx prenatal vitamins with changes to the amounts of folic acid and iron.  

According to the American Congress of Obstetricians and Gynecologists (ACOG), women need extra iron and folic acid during pregnancy.(1)  PreNexa®'s newest formulation contains 1.25 mg of folic acid and 27 mg of iron.(2)  Folic acid supplementation, in addition to a healthy diet, can help reduce the risk of neural tube defects such as spina bifida during fetal development.  Iron supports the formation of healthy red blood cells.(1)

In addition to folic acid and iron, PreNexa® contains essential vitamins and minerals that are important in the overall health and well-being of mother and baby including calcium, vitamins B6, C, D3 and 300 mg of plant-based docosahexaenoic acid (DHA) in one single gel capsule taken once a day.  

"PreNexa®'s newest formulation continues to demonstrate Upsher-Smith's commitment to expectant mothers by providing essential nutrients in an all-in-one prenatal vitamin," said Wesley Mark Todd, MD, Senior Director Medical Affairs, Upsher-Smith Laboratories, Inc.  "A balanced diet is a fundamental part of good health at all times, but especially during pregnancy.  Upsher-Smith is pleased to have the opportunity to help women achieve this important goal before, during, and after pregnancy."

The NDC number for the new formulation of PreNexa® is 0245-0178-30.  Key product features remain the same, including: the bottle configuration, amount per bottle (30 gel capsules), look of the gel capsule, and regimen of one pill once daily.  

Important Safety Information

Please see full Prescribing Information for a complete list of warnings and precautions.

Warning: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under six.  KEEP THIS PRODUCT OUT OF REACH OF CHILDREN.  In case of accidental overdose, call a doctor or poison control center immediately.

About Upsher-Smith

Upsher-Smith Laboratories, Inc. is a rapidly growing pharmaceutical company that manufactures and markets both prescription and consumer products.  Privately held since 1919, the company strives to recognize the unmet healthcare needs of its customers.  Upsher-Smith prides itself on providing safe, effective, and economical therapies to the ever-challenged healthcare environment.  For additional information about PreNexa®, visit www.prenexa.com, or to learn more about Upsher-Smith, visit www.upsher-smith.com.    

References

(1) The American College of Obstetricians and Gynecologists ACOG.  ACOG education pamphlet.  Nutrition during pregnancy.  http://www.acog.org/publications/patient_education/bp001.cfm.  Accessed May 21, 2010.

(2) PreNexa (package insert).  Minneapolis, MN: Upsher-Smith Laboratories, Inc; 2010.


'/>"/>
SOURCE Upsher-Smith Laboratories, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Upsher-Smith Announces New Formulation of PreNexa(R) Prenatal Vitamins
2. New Data: Cholesterol Management Analysis of Upsher-Smiths Slo-Niacin(R) Tablets in Combination with Lipitor(R)
3. Upsher-Smith Announces Milestone in Development of CNS Strategy
4. Quest Diagnostics Introduces ClariSure(TM) Test for Identifying Chromosome Abnormalities Associated With 85 Developmental Disorders in Children
5. Dr. Dello Russo Introduces the New EYE-Q Lasik
6. Caliper Life Sciences Introduces Drug Combination Services to Identify Synergistic Response of Compounds
7. Wedgewood Introduces Refresh(TM) Exchange-Program: Free Exchange of Expired Veterinary Compounded Medications Solves Key Industry Problem
8. CeloNova BioSciences Introduces a New Class of Coronary Stent: The CATANIA(TM) Coronary Stent System with NanoThin Polyzene(R)-F
9. Thermo Fisher Scientific Introduces Breakthrough in RNA-Interference Technology
10. Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C
11. Siemens Introduces New Standard of Care for Breast Ultrasound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... Period October – December 2016 Revenues amounted ... -16.4 (-6.4) million Result after tax amounted to SEK -16.3 ... Cash flow from operating activities amounted to SEK -8.3 (-7.3) ... Period full year 2016 ... Operating result amounted to SEK -39.5 (-29.5) million Result ...
(Date:2/24/2017)... YORK , February 24, 2017 Following ... Israel , s AMAR ... $ 250 M w ound care market ... s BST for inclusion in the ... healthcare reimbursement system   E-QURE Corp. (OTCQB: ...
(Date:2/24/2017)... -- Research and Markets has announced the addition of the ... 2025" report to their offering. ... The Global Empty Capsules Market is poised to grow at ... $2.9 billion by 2025. This industry report analyzes the ... well as regional levels presented in the research scope. The study provides ...
Breaking Medicine Technology:
(Date:2/26/2017)... Florida (PRWEB) , ... February 26, 2017 , ... ... of Parkinson’s disease (PD) in persons with a specific LRRK2 mutation, according to ... Congress. , Previous studies have provided evidence of a link between pesticides and ...
(Date:2/24/2017)... ... February 24, 2017 , ... Houston dentist ... his office, Antoine Dental Center. Currently, patients can get single dental implants for ... but patients can learn more about these offers by contacting Antoine Dental Center. ...
(Date:2/24/2017)... ... 2017 , ... An in-depth computational analysis of genetic variants implicated in both ... genes that may explain why susceptibility to one of the disorders could place individuals ... today in the journal npj Schizophrenia. , “There is a wealth of genomic ...
(Date:2/24/2017)... ... February 24, 2017 , ... In the Health Care ... a top priority because it’s not if you will be attacked, but when.” However, ... it comes to digital health care. , Improvements in auditing and monitoring have taken ...
(Date:2/24/2017)... ... ... The narrative in “ Signal 8: An Australian Paramedic’s Story ” (published by ... Schanssema describes the tragedies he saw, as well as his struggles with grief and ... unsure of the career path he wanted to take, found fulfillment in a career ...
Breaking Medicine News(10 mins):